phenylalanylarginine has been researched along with ciprofloxacin in 2 studies
*Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline. [MeSH]
*Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline. [MeSH]
Studies (phenylalanylarginine) | Trials (phenylalanylarginine) | Recent Studies (post-2010) (phenylalanylarginine) | Studies (ciprofloxacin) | Trials (ciprofloxacin) | Recent Studies (post-2010) (ciprofloxacin) |
---|---|---|---|---|---|
17 | 0 | 10 | 16,060 | 1,331 | 6,092 |
Protein | Taxonomy | phenylalanylarginine (IC50) | ciprofloxacin (IC50) |
---|---|---|---|
Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | 0.41 | |
DNA gyrase subunit B | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
DNA gyrase subunit A | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.31 | |
DNA gyrase subunit B | Staphylococcus aureus | 4.32 | |
DNA gyrase subunit A | Escherichia coli K-12 | 0.6845 | |
DNA gyrase subunit B | Escherichia coli K-12 | 0.5632 | |
DNA topoisomerase 4 subunit B | Staphylococcus aureus | 6.485 | |
DNA topoisomerase 4 subunit A | Staphylococcus aureus | 4.8011 | |
Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.41 | |
DNA gyrase subunit A | Staphylococcus aureus | 4.32 | |
Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.41 | |
DNA topoisomerase 4 subunit A | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
DNA topoisomerase 4 subunit B | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
GABA theta subunit | Rattus norvegicus (Norway rat) | 0.41 | |
Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | 0.41 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Del Valle, LJ; Gomes, C; Mosquito, S; Ochoa, TJ; Pons, MJ; Ruiz, J | 1 |
Li, Y; Liu, M; Qi, Q; Xu, L; Zhang, Y | 1 |
2 other study(ies) available for phenylalanylarginine and ciprofloxacin
Article | Year |
---|---|
Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Peru; Prevalence; Quinolones | 2014 |
[Effects of antibiotics plus efflux pump inhibitors on mutant selection window of Pseudomonas aeruginosa in vitro].
Topics: Amikacin; Antibiotics, Antitubercular; Ciprofloxacin; Dipeptides; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 2014 |